Filing Details
- Accession Number:
- 0001214659-20-006178
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-07 20:05:16
- Reporting Period:
- 2020-07-02
- Accepted Time:
- 2020-07-07 20:05:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1755970 | John Patrick Finn | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-07-02 | 1,400 | $46.68 | 37,697 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 22, 2019.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $46.66 to $46.73 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.